ARMANDO ANIDO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ARMANDO ANIDO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARMANDO ANIDO. ARMANDO ANIDO is EVP, Sales & Marketing in MEDIMMUNE INC /DE ($MEDI) and Director in Aviragen Therapeutics, Inc. ($NABI) and Director in ADOLOR CORP ($ADLR) and Director in SCYNEXIS INC ($SCYX) and Chairman & Chief Exec Officer in Zynerba Pharmaceuticals, Inc. ($ZYNE) and Chairman & Chief Exec. Officer in Zynerba Pharmaceuticals, Inc. ($ZYNE).
Latest Insider Trading Transactions of ARMANDO ANIDO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, MEDI, SCYX, VXRT, ZYNE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 3.58 | 161,867 | 579,484 | 161,867 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Grant | A | 0.00 | 107,911 | 0 | 460,423 | 352.5 K to 460.4 K (+30.61 %) |
| Dec 23 2020 | SCYX | SCYNEXIS INC | ANIDO ARMANDO | Director | Option Exercise | A | 8.25 | 2,500 | 20,625 | 2,500 | |
| Dec 23 2020 | SCYX | SCYNEXIS INC | ANIDO ARMANDO | Director | Option Exercise | A | 7.33 | 2,500 | 18,325 | 2,500 | |
| Dec 23 2020 | SCYX | SCYNEXIS INC | ANIDO ARMANDO | Director | Buy | P | 6.25 | 5,000 | 31,250 | 5,000 | 0 to 5 K |
| Jul 08 2020 | SCYX | SCYNEXIS INC | ANIDO ARMANDO | Director | Option Exercise | A | 0.73 | 45,000 | 32,850 | 45,000 | |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 5.05 | 162,480 | 820,524 | 162,480 | |
| Jun 20 2019 | SCYX | SCYNEXIS INC | ANIDO ARMANDO | Director | Option Exercise | A | 1.29 | 45,000 | 58,050 | 45,000 | |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 3.65 | 160,000 | 584,000 | 160,000 | |
| Jan 23 2019 | SCYX | SCYNEXIS INC | ANIDO ARMANDO | Director | Option Exercise | A | 0.74 | 70,000 | 51,975 | 70,000 | |
| Aug 07 2018 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | P | 5.96 | 15,000 | 89,423 | 352,512 | 337.5 K to 352.5 K (+4.44 %) |
| Jan 16 2018 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 11.71 | 81,000 | 948,510 | 81,000 | |
| May 22 2017 | AVIR | Aviragen Therapeut ... | ANIDO ARMANDO | Director | Option Exercise | A | 0.49 | 20,000 | 9,800 | 75,000 | |
| May 16 2017 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | P | 19.57 | 1,500 | 29,355 | 337,512 | 336 K to 337.5 K (+0.45 %) |
| May 16 2017 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | P | 19.76 | 3,500 | 69,160 | 336,012 | 332.5 K to 336 K (+1.05 %) |
| Jan 26 2017 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 18.22 | 125,000 | 2,277,500 | 125,000 | |
| May 13 2016 | NABI | Aviragen Therapeut ... | ANIDO ARMANDO | Director | Option Exercise | A | 1.50 | 20,000 | 30,000 | 20,000 | |
| Oct 21 2015 | NABI | Aviragen Therapeut ... | ANIDO ARMANDO | Director | Option Exercise | A | 1.95 | 35,000 | 68,250 | 35,000 | |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | C | 0.00 | 13,297 | 0 | 13,297 | 0 to 13.3 K |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | C | 0.00 | 26,595 | 0 | 26,595 | 0 to 26.6 K |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 14.00 | 396,678 | 5,553,492 | 396,678 | |
| Nov 09 2005 | MEDI | MEDIMMUNE INC /DE | ANIDO ARMANDO | EVP, Sales & Market ... | Option Exercise | M | 23.45 | 26,250 | 615,563 | 43,750 | |
| Nov 09 2005 | MEDI | MEDIMMUNE INC /DE | ANIDO ARMANDO | EVP, Sales & Market ... | Option Exercise | M | 24.17 | 14,375 | 347,444 | 100,625 | |
| Nov 09 2005 | MEDI | MEDIMMUNE INC /DE | ANIDO ARMANDO | EVP, Sales & Market ... | Sell | S | 34.90 | 40,625 | 1,417,837 | 1,472 | 42.1 K to 1.5 K (-96.50 %) |
| Nov 09 2005 | MEDI | MEDIMMUNE INC /DE | ANIDO ARMANDO | EVP, Sales & Market ... | Buy | M | 23.45 | 26,250 | 615,563 | 42,097 | 15.8 K to 42.1 K (+165.65 %) |
| Nov 09 2005 | MEDI | MEDIMMUNE INC /DE | ANIDO ARMANDO | EVP, Sales & Market ... | Buy | M | 24.17 | 14,375 | 347,444 | 15,847 | 1.5 K to 15.8 K (+976.56 %) |
| Jun 16 2005 | ADLR | ADOLOR CORP | ANIDO ARMANDO | Director | Option Exercise | A | 8.94 | 15,000 | 134,100 | 15,000 | |
| May 13 2004 | ADLR | ADOLOR CORP | ANIDO ARMANDO | Director | Option Exercise | A | 15.35 | 15,000 | 230,250 | 15,000 |
Page: 1